NRx Pharmaceuticals Highlights Real-World Ketamine Depression Data
MIAMI, June 5, 2026 NRx Pharmaceuticals, Inc. announced that new real-world evidence presented at the 2026 American Society of...
ASCP 2026
Advertisement
BioXcel Reports Positive Phase 3 At-Home Agitation Data
NEW HAVEN, Conn. | May 28, 2026 BioXcel Therapeutics presented new positive data from its Phase 3 SERENITY At-Home...
Tonix Highlights Real-World Opioid Burden in Fibromyalgia at ASCP 2026
BERKELEY HEIGHTS, N.J., May 28, 2026 Tonix Pharmaceuticals presented new real-world data at the 2026 American Society of Clinical...
Johnson & Johnson Showcases Neuropsychiatry Data at APA 2026
TITUSVILLE, N.J., May 11, 2026 Johnson & Johnson announced the presentation of 18 new and encore abstracts highlighting the...
Advertisement
